China Health Group Inc. (8225.HK)
HKD 0.15
(5.56%)
HKD 0.15
(5.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.42 Million CNY | 63.67% |
| 2022 | 13.09 Million CNY | -84.34% |
| 2021 | 83.6 Million CNY | 0.65% |
| 2020 | 83.06 Million CNY | 31.4% |
| 2019 | 63.21 Million CNY | 6.06% |
| 2018 | 59.6 Million CNY | 1.91% |
| 2017 | 58.49 Million CNY | 188.97% |
| 2016 | 20.24 Million CNY | -1.25% |
| 2015 | 20.49 Million CNY | 244.14% |
| 2014 | 5.95 Million CNY | -60.11% |
| 2013 | 14.93 Million CNY | -47.95% |
| 2012 | 28.68 Million CNY | 58.51% |
| 2011 | 18.09 Million CNY | -51.98% |
| 2010 | 37.68 Million CNY | -20.34% |
| 2009 | 47.3 Million CNY | 20.73% |
| 2008 | 39.18 Million CNY | 1.18% |
| 2007 | 38.72 Million CNY | -32.12% |
| 2006 | 57.05 Million CNY | 35.33% |
| 2005 | 42.15 Million CNY | 16.59% |
| 2004 | 36.15 Million CNY | 1.34% |
| 2003 | 35.68 Million CNY | 9.94% |
| 2002 | 32.45 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q4 | 3.53 Million CNY | 23.07% |
| 2023 FY | 21.42 Million CNY | 63.67% |
| 2023 Q1 | 4 Million CNY | 119.78% |
| 2023 Q2 | 11.02 Million CNY | 175.53% |
| 2023 Q3 | 2.86 Million CNY | -73.97% |
| 2022 FY | 13.09 Million CNY | -84.34% |
| 2022 Q2 | 16.14 Million CNY | 14.11% |
| 2022 Q3 | 3.01 Million CNY | -81.32% |
| 2022 Q4 | -20.22 Million CNY | -770.4% |
| 2022 Q1 | 14.15 Million CNY | -49.05% |
| 2021 Q4 | 27.77 Million CNY | 259.0% |
| 2021 FY | 83.6 Million CNY | 0.65% |
| 2021 Q1 | 26.22 Million CNY | -17.02% |
| 2021 Q2 | 21.86 Million CNY | -16.62% |
| 2021 Q3 | 7.73 Million CNY | -64.62% |
| 2020 Q4 | 31.6 Million CNY | 235.02% |
| 2020 Q3 | 9.43 Million CNY | -53.87% |
| 2020 Q2 | 20.45 Million CNY | -5.19% |
| 2020 FY | 83.06 Million CNY | 31.4% |
| 2020 Q1 | 21.57 Million CNY | -8.62% |
| 2019 Q4 | 23.6 Million CNY | 187.96% |
| 2019 Q2 | 15.06 Million CNY | -7.81% |
| 2019 Q1 | 16.34 Million CNY | -21.83% |
| 2019 Q3 | 8.19 Million CNY | -45.59% |
| 2019 FY | 63.21 Million CNY | 6.06% |
| 2018 FY | 59.6 Million CNY | 1.91% |
| 2018 Q4 | 20.9 Million CNY | 180.58% |
| 2018 Q3 | 7.45 Million CNY | -53.98% |
| 2018 Q2 | 16.19 Million CNY | 7.59% |
| 2018 Q1 | 15.05 Million CNY | -50.4% |
| 2017 FY | 58.49 Million CNY | 188.97% |
| 2017 Q3 | 12.04 Million CNY | 54.17% |
| 2017 Q4 | 30.34 Million CNY | 151.97% |
| 2017 Q2 | 7.81 Million CNY | -5.74% |
| 2017 Q1 | 8.28 Million CNY | 279.66% |
| 2016 Q2 | 8.95 Million CNY | 34.1% |
| 2016 FY | 20.24 Million CNY | -1.25% |
| 2016 Q4 | 2.18 Million CNY | -10.31% |
| 2016 Q1 | 6.67 Million CNY | -48.21% |
| 2016 Q3 | 2.43 Million CNY | -72.8% |
| 2015 Q4 | 12.88 Million CNY | 375.32% |
| 2015 Q1 | 893 Thousand CNY | 244.97% |
| 2015 FY | 20.49 Million CNY | 244.14% |
| 2015 Q2 | 4 Million CNY | 348.71% |
| 2015 Q3 | 2.71 Million CNY | -32.34% |
| 2014 Q1 | 2.89 Million CNY | 21.66% |
| 2014 FY | 5.95 Million CNY | -60.11% |
| 2014 Q3 | 2.38 Million CNY | 83.22% |
| 2014 Q2 | 1.29 Million CNY | -55.1% |
| 2014 Q4 | -616 Thousand CNY | -125.88% |
| 2013 Q3 | 1.34 Million CNY | -26.22% |
| 2013 Q1 | 9.37 Million CNY | 38.05% |
| 2013 FY | 14.93 Million CNY | -47.95% |
| 2013 Q4 | 2.37 Million CNY | 76.41% |
| 2013 Q2 | 1.82 Million CNY | -80.52% |
| 2012 Q4 | 6.79 Million CNY | 4.62% |
| 2012 FY | 28.68 Million CNY | 58.51% |
| 2012 Q3 | 6.49 Million CNY | 0.0% |
| 2011 Q2 | 9.51 Million CNY | 0.0% |
| 2011 Q4 | -15.37 Million CNY | -262.54% |
| 2011 FY | 18.09 Million CNY | -51.98% |
| 2011 Q3 | 9.45 Million CNY | -0.59% |
| 2010 FY | 37.68 Million CNY | -20.34% |
| 2010 Q1 | 12.82 Million CNY | 74.7% |
| 2010 Q2 | 12.96 Million CNY | 1.09% |
| 2010 Q3 | 11.61 Million CNY | -10.41% |
| 2010 Q4 | 282 Thousand CNY | -97.57% |
| 2009 Q2 | 7.7 Million CNY | 0.0% |
| 2009 FY | 47.3 Million CNY | 20.73% |
| 2009 Q3 | 20.51 Million CNY | 166.29% |
| 2009 Q4 | 7.34 Million CNY | -64.22% |
| 2008 FY | 39.18 Million CNY | 1.18% |
| 2007 FY | 38.72 Million CNY | -32.12% |
| 2006 FY | 57.05 Million CNY | 35.33% |
| 2005 FY | 42.15 Million CNY | 16.59% |
| 2004 FY | 36.15 Million CNY | 1.34% |
| 2003 FY | 35.68 Million CNY | 9.94% |
| 2002 FY | 32.45 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Life Healthcare Group Limited | 233.68 Million HKD | 90.832% |
| China Biotech Services Holdings Limited | 211.98 Million HKD | 89.893% |